Under section 564 of the Federal Food, Drug, and Cosmetic Act, the FDA commissioner may allow unapproved medical products in response to a chemical, biological, radiological or nuclear (CBRN)threat.
(3)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.